1990
DOI: 10.1172/jci114925
|View full text |Cite
|
Sign up to set email alerts
|

The core polypeptide of cystic fibrosis tracheal mucin contains a tandem repeat structure. Evidence for a common mucin in airway and gastrointestinal tissue.

Abstract: A cystic fibrosis trachea cDNA library was constructed and probed with a synthetic oligonucleotide containing a consensus sequence recently identified in human intestinal mucin. One of the isolated clones, AMN-22, has been characterized extensively. The cDNA sequence of this 884-bp fragment was determined, and revealed a tandem repeat structure rich in threonine and proline residues. The repeating sequence of AMN-22 was similar but not identical to that determined for gut mucin.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
25
0

Year Published

1991
1991
2000
2000

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 63 publications
(25 citation statements)
references
References 23 publications
0
25
0
Order By: Relevance
“…Discussion MUC-2 polymorphisms. All four of the currently known human mucin genes have been found to be polymorphic (2)(3)(4)(5)(6)(7)(8)(9)(10)(11)(12)(13)(14). The MUC-1 gene has been the most thoroughly examined in this respect.…”
Section: Resultsmentioning
confidence: 99%
See 2 more Smart Citations
“…Discussion MUC-2 polymorphisms. All four of the currently known human mucin genes have been found to be polymorphic (2)(3)(4)(5)(6)(7)(8)(9)(10)(11)(12)(13)(14). The MUC-1 gene has been the most thoroughly examined in this respect.…”
Section: Resultsmentioning
confidence: 99%
“…Four human mucins have been described and at least partially characterized (2)(3)(4)(5)(6)(7)(8)(9)(10)(11)(12)(13)(14). All of these genes have been found Our laboratory has cloned partial cDNAs that are derived from two different human intestinal mucin genes, MUC-2 and MUC-3 (9,13).…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…*Despite the success of MUC1 VNTR-reactive MAbs, only a few MAbs reacting with other VNTR have been reported Price et al, 1991), and the use of these MAbs for diagnosis and therapy has not been investigated. The MUC2 mucin is of particular interest since this is a major component of mucus produced by patients with colon and lung cancer, as well as those with cystic fibrosis (Gum et al, 1989;Gerard et al, 1990;Jany et al, 1991). Subsequently, by immunising with native colon cancer mucin and a KLH-synthetic peptide conjugate containing the 23 amino acid MUC2 VNTR sequence, we have produced anti-MUC2 VNTR MAbs which react with the intact mucin.…”
mentioning
confidence: 99%
“…So far, nine families of cDNAs encoding human mucins have been cloned from breast tumour cells (MUCI) [2,3,4] jejunum mucosa as well as tracheobronchial mucosa (MUC2) [5,6,7], jejunum mucosa (MUC3) [8], tracheobronchial mucosa (MUC4, 5A, 5B, 5C) [9,10], stomach (MUC6) [11] and submandibular gland (MUC7) [12].…”
Section: Introductionmentioning
confidence: 99%